Given the Hellscape that is "cancer therapies" today, your best bet will be to hammer home, constantly, LLMab's *impeccable* safety profile.... Lack of SAEs, well tolerated, one thousand patients over five years, in a population as fragile as HIV patients... "It won't hurt and there's nothing to lose" is what needs to be understood. I wish you both the best of luck....

Encountered this wall with trying to get a friend with CV19 treated, they went with an IL6 blocker instead, he nearly died. It won't be easy.